Page last updated: 2024-10-18

dihydroxyphenylalanine and Experimental Hepatoma

dihydroxyphenylalanine has been researched along with Experimental Hepatoma in 2 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Martiniova, L1
Lai, EW1
Thomasson, D1
Kiesewetter, DO1
Seidel, J1
Merino, MJ1
Kvetnansky, R1
Pacak, K1
BUTTLE, GA1
EPERON, J1
KAMESWARAN, L1
WEST, GB1

Other Studies

2 other studies available for dihydroxyphenylalanine and Experimental Hepatoma

ArticleYear
Animal model of metastatic pheochromocytoma: evaluation by MRI and PET.
    Endocrine regulations, 2009, Volume: 43, Issue:2

    Topics: Adrenal Gland Neoplasms; Animals; Dihydroxyphenylalanine; Disease Models, Animal; Dopamine; Female;

2009
Histamine formation and tumor growth.
    British journal of cancer, 1962, Volume: 16

    Topics: Animals; Carcinoma, Hepatocellular; Dihydroxyphenylalanine; Histamine; Liver Neoplasms; Liver Neopla

1962